34 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
1 May 24
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
8:00am
with achievement of this important clinical development milestone as we continue to build our leadership in influenza therapeutics.”
In March 2024 Cocrystal
8-K
EX-99.1
0lvkbrjvegb2macb1x
24 Apr 23
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors
8:13am
DEFA14A
a9h09ur2j2vbnhav
28 May 21
Additional proxy soliciting materials
8:10am
8-K
EX-99.1
erkhg1
28 May 21
Cocrystal Pharma Announces the Passing of Chairman, CEO and Co-founder Dr. Gary Wilcox
8:05am
8-K
EX-99.1
89jgn6w m02w3q6l
20 Apr 20
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
8:05am